Phase II trial of gemcitabine plus UFT as salvage treatment in oxaliplatin, irinotecan and fluoropyrimidine-refractory metastatic colorectal cancer

被引：0
作者：
Keun-Wook Lee
Yu Jung Kim
Kyung-Hun Lee
Sae-Won Han
Tae-Yong Kim
Do-Youn Oh
Seock-Ah Im
Tae-You Kim
Yung-Jue Bang
In Sil Choi
Jee Hyun Kim
机构：
[1] Seoul National University College of Medicine,Department of Internal Medicine, Seoul National University Bundang Hospital
[2] Seoul National University College of Medicine,Department of Internal Medicine, Seoul National University Hospital
[3] Seoul National University College of Medicine,Department of Internal Medicine, SMG
来源：
Cancer Chemotherapy and Pharmacology | 2014年 / 74卷
关键词：
Metastatic colorectal cancer; Chemotherapy; Refractory; Gemcitabine; UFT;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：447 / 455
页数：8
相关论文
共 50 条
  • [41] Phase II study of UFT with leucovorin and irinotecan (TEGAFIRI):: first-line therapy for metastatic colorectal cancer
    Delord, J-P
    Bennouna, J.
    Artru, P.
    Perrier, H.
    Husseini, F.
    Desseigne, F.
    Francois, E.
    Faroux, R.
    Smith, D.
    Piedbois, P.
    Naman, H.
    Douillard, J. Y.
    Bugat, R.
    BRITISH JOURNAL OF CANCER, 2007, 97 (03) : 297 - 301
  • [42] Combination chemotherapy of biweekly irinotecan (CPT-11) plus tegafur/uracil (UFT) and leucovorin (LV) for patients with metastatic colorectal cancer: phase I/II study in Japanese patients
    Okabayashi, Koji
    Hasegawa, Hirotoshi
    Ishii, Yoshiyuki
    Endo, Takashi
    Ochiai, Hiroki
    Kubota, Tetsuro
    Kitagawa, Yuko
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 63 (03) : 501 - 507
  • [43] A multicenter phase II trial of docetaxel plus gemcitabine as salvage treatment in anthracycline- and taxane-pretreated patients with metastatic breast cancer
    N. Karachaliou
    Ch. Kouroussis
    P. Papakotoulas
    K. Kalbakis
    K. Tryfonidis
    N. Vardakis
    E. Poppis
    V. Georgoulias
    D. Mavroudis
    Cancer Chemotherapy and Pharmacology, 2012, 69 : 1345 - 1352
  • [44] Randomised phase II trial of gemcitabine plus vinorelbine vs gemcitabine plus cisplatin vs gemcitabine plus capecitabine in patients with pretreated metastatic breast cancer
    Stemmler, H. J.
    diGioia, D.
    Freier, W.
    Tessen, H. W.
    Gitsch, G.
    Jonat, W.
    Brugger, W.
    Kettner, E.
    Abenhardt, W.
    Tesch, H.
    Hurtz, H. J.
    Roesel, S.
    Brudler, O.
    Heinemann, V.
    BRITISH JOURNAL OF CANCER, 2011, 104 (07) : 1071 - 1078
  • [45] Phase II study of oxaliplatin, UFT, and leucovorin in patients with metastatic gastric cancer
    Ester J. M. Siemerink
    Annemieke F. J. Drenth
    Nanno H. Mulder
    John T. M. Plukker
    Geke A. P. Hospers
    Gastric Cancer, 2010, 13 : 95 - 100
  • [46] Capecitabine plus oxaliplatin (CapOx) versus capecitabine plus gemcitabine (CapGem) versus gemcitabine plus oxaliplatin (mGemOx): final results of a multicenter randomized phase II trial in advanced pancreatic cancer
    Boeck, S.
    Hoehler, T.
    Seipelt, G.
    Mahlberg, R.
    Wein, A.
    Hochhaus, A.
    Boeck, H. -P.
    Schmid, B.
    Kettner, E.
    Stauchlo, M.
    Lordick, F.
    Ko, Y.
    Geissler, M.
    Schoppmeyer, K.
    Kojouharoff, G.
    Golf, A.
    Neugebauer, S.
    Heinemann, V.
    ANNALS OF ONCOLOGY, 2008, 19 (02) : 340 - 347
  • [47] Bevacizumab plus gemcitabine and oxaliplatin as first-line therapy for metastatic or locally advanced pancreatic cancer: a phase II trial
    Fogelman, David
    Jafari, Mehrdad
    Varadhachary, Gauri R.
    Xiong, Henry
    Bullock, Susie
    Ozer, Harold
    Lin, E.
    Morris, Jeffrey
    Cunningham, Patti
    Bennett, Bronwyn
    Abbruzzese, James L.
    Wolff, Robert A.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 68 (06) : 1431 - 1438
  • [48] A phase I/II study of arfolitixorin and 5-fluorouracil in combination with oxaliplatin (plus or minus bevacizumab) or irinotecan in metastatic colorectal cancer
    Carlsson, G.
    Koumarianou, A.
    Guren, T. K.
    Haux, J.
    Katsaounis, P.
    Kentepozidis, N.
    Pfeiffer, P.
    Braendengen, M.
    Mavroudis, D.
    Taffin, H.
    Skintemo, L.
    Tell, R.
    Papadimitriou, C.
    ESMO OPEN, 2022, 7 (05)
  • [49] Combining capecitabine, oxaliplatin, and gemcitabine (XELOXGEM) for colorectal carcinoma patients pretreated with irinotecan: a multicenter phase I/II trial
    Se Hyun Kim
    Sang Joon Shin
    Sun Young Kim
    Se Hoon Lee
    Young Suk Park
    Se Hoon Park
    Kyung Hee Lee
    Tae Won Kim
    Yong Sang Hong
    Joong Bae Ahn
    Cancer Chemotherapy and Pharmacology, 2012, 69 : 91 - 97
  • [50] Bioavailability and phase II study of oral UFT plus leucovorin in patients with relapsed or refractory colorectal cancer
    Meropol, NJ
    Sonnichsen, DS
    Birkhofer, MJ
    Ferreira, I
    Noel, D
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1999, 43 (03) : 221 - 226
12345